Intero Biosystems wants drugmakers to test on mini human intestines, not animals
Originally published by TechCrunch
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
Original reporting
Read the full story at the original publisher
PulsePress is a news discovery platform. We bring headlines from multiple publishers together so you can discover stories in one place. The complete reporting remains with the original publisher.
Read original article →